Follow-up testing for tumorigenicity and oncogenicity.
Ended Purchase Order Awarded Last action
- Contract number
- 75D30124P19870
- Awardee
-
Bioreliance Corporation UEI H3KAG9A26K77
- Awarding agency
-
CDC Pittsburgh
Centers for Disease Control and Prevention, Department of Health and Human Services
- Obligated
- $248,779
Award facts
- Opportunity
-
- Follow-up testing for tumorigenicity and oncogenicity Pre-Solicitation · 75D30124Q78224 · Posted Aug 19, 2024
- Contract value 100% obligated
- $248,779.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 621511 Medical Laboratories
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 2 offers Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Denver, CO 80225, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $248,779 |
About this award
CDC Pittsburgh awarded a purchase order to Bioreliance Corporation for $248,779 on September 26, 2024, to conduct follow-up tumorigenicity and oncogenicity testing on the Expi293F Master Cell Bank supporting influenza vaccine development. Work is performed in Denver, Colorado, with an ultimate completion date of September 24, 2026. The order requires 21 CFR and cGLP-compliant in vivo oncogenicity testing via newborn nude mice. Bioreliance, a Life Sciences Services Division of Sigma-Aldrich, is a foreign-owned testing laboratory providing specialized microbiological and biochemical testing services to federal health research agencies. The order originated from a pre-solicitation sources sought notice posted August 19, 2024, with responses due August 25, 2024.
Quick answers
Who was awarded contract 75D30124P19870?
75D30124P19870 was awarded to Bioreliance Corporation by CDC Pittsburgh (Centers for Disease Control and Prevention) on September 26, 2024.
How much is contract 75D30124P19870 worth?
The government has obligated $248,779 on 75D30124P19870.
Was contract 75D30124P19870 competed?
The extent of competition for 75D30124P19870 was competed under sap. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award